Clinical Trials on Healthy Normal Volunteers in Belgium

Total 693 results

Pfizer

Terminated

Topical Multiple Ascending Dose Study for PF-06423264

Normal Healthy

Belgium
Regeneron Pharmaceuticals

Completed

A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers

Healthy Volunteers

Belgium
Pfizer

Completed

Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)

Healthy Volunteers

Belgium
Pfizer

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects

Healthy Volunteers

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

The Effects of Intragastric Administration of Nutrients on Executive Control in Healthy Subjects.

Healthy Volunteers

Belgium
Pfizer

Completed

A Study to Estimate the Effect of CYP3A4 Inhibitors (Itraconazole, Diltiazem or Verapamil) on the Pharmacokinetics of Single Dose PF- 00489791 in Healthy Volunteers

Healthy Volunteers

Belgium
Pfizer

Completed

A Study Comparing The Amounts of Tafamidis In The Blood With Or Without Food

Healthy Volunteers

Belgium
University of Liege

Completed

Neurophysiological Study of tDCS Effects in Healthy Volunteers (tDCSHV)

Healthy Volunteers

Belgium
Pfizer

Completed

A Bioequivalence Study Comparing Two Different Tafamidis Formulations

Healthy Volunteers

Belgium
Janssen Research & Development, LLC

Completed

A Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Participants

Healthy Volunteers

Belgium
Pfizer

Completed

Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804)

Healthy Volunteers

Belgium
Pierre Fabre Medicament

Completed

Evaluation and Comparison of Systemic Exposure to Ibuprofen After Single Oromucosal Versus Oral Administrations

Healthy Volunteers

Belgium
Pfizer
Medivation, Inc.

Completed

A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults

Healthy Volunteers

Belgium
Guerbet

Completed

Cardiac Safety Evaluation of P03277

Healthy Volunteers

Belgium
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Regeneron Pharmaceuticals
Sanofi

Completed

A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult Subjects

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects

Healthy Volunteers

Belgium
Pfizer

Completed

A Relative Bioavailability Study To Evaluate Safety, Tolerability And Pharmacokinetic Comparability Of Pegvisomant 1 X 30 Mg Vs 2 X 15 Mg Subcutaneously Administered In Healthy Subjects

Healthy Volunteers

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

In Vivo Inhibition Profile of CYP2C9 by Pineapple Juice

Healthy Volunteers

Belgium
Pfizer

Completed

Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects

Healthy Volunteers

Belgium
Pfizer

Completed

A Phase 1 Multiple-Dose Escalation and Single Dose (Tablet) Study of PF-04171327 in Healthy Volunteers

Healthy Volunteers

Belgium
Pfizer

Completed

Food Effect Study Of AG-013736 In Healthy Volunteers

Healthy Volunteers

Belgium
Boehringer Ingelheim

Completed

A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321

Healthy Volunteers

Belgium
Biocodex

Completed

Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin

Healthy Volunteers

Belgium
Pfizer

Completed

A Phase 1 Study To Evaluate The Effect Of Glasdegib On The Cardiac Repolarization In Healthy Subjects (B1371023)

Healthy Volunteers

Belgium
Pfizer

Completed

Drug-Drug Interaction Study to Evaluate the Effect of PF-06865571 on Metformin Pharmacokinetics

Healthy Volunteers

Belgium
Regeneron Pharmaceuticals

Completed

A Study to Examine the Safety and Tolerability of Single Ascending Doses of REGN2477

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples

Healthy Volunteers

Belgium
Janssen Research & Development, LLC

Completed

A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men

Healthy Volunteers

Belgium
Pfizer

Completed

A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804

Healthy Volunteers

Belgium
Pfizer

Completed

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

Healthy Volunteers

Belgium
Pfizer

Completed

Bioavailability Of Lersivirine Single 750 Mg Tablet Versus 3 X 250 Mg Tablets

Healthy Volunteers

Belgium
Pfizer

Completed

A Study To Evaluate The Safety, Tolerability And Pharmacokinetics Of Single Oral Doses Of PF-03716539 In Healthy Adult Subjects

Healthy Volunteers

Belgium
Universiteit Antwerpen
Abbott

Completed

Selection of Antibiotic Resistance by Azithromycin and Clarithromycin in the Oral Flora

Healthy Volunteers

Belgium
University Hospital, Antwerp
Molecular Targeting Technologies, Inc.

Completed

Biodistribution and Dosimetry of 99mTc-Duramycin (PicTURE)

Healthy Volunteers

Belgium
Regeneron Pharmaceuticals

Completed

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of REGN9933 in Adult Healthy Volunteers

Healthy Volunteers

Belgium
Janssen-Cilag International NV

Completed

A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants

Healthy Volunteers | Pharmacokinetics

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Biomarker Development for Future PAC1 Antagonists With Maxadilan

Healthy Volunteers

Belgium
University Hospital, Antwerp
Baxter Healthcare Corporation

Completed

Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults (MIHMoSA)

Healthy Adult Volunteers

Belgium
Celgene

Terminated

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Participants

Healthy Volunteers

Belgium
Celgene

Completed

Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Before and After CC-97489 Administration in Healthy Participants

Healthy Volunteers

Belgium
Guerbet

Completed

Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions

Healthy Volunteers | Brain Lesion

Belgium
Pfizer

Completed

Study to Evaluate the Effect of Repeat-Dose Rifampin on the Pharmacokinetics (PK) of PF-06651600

Healthy Volunteers

Belgium
Pfizer

Completed

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

Healthy Volunteers

Belgium
Pfizer

Completed

A Study of PF-06651600 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants

Healthy Volunteers

Belgium
Regeneron Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetics of REGN5069 in Healthy Volunteers

Healthy Volunteer

Belgium
Pfizer
ViiV Healthcare

Completed

Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-release Lersivirine 500 mg in Healthy Subjects

Healthy Volunteer

Belgium
Regeneron Pharmaceuticals

Terminated

Ascending Dose Study of the Safety and Tolerability of REGN6490 in Healthy Volunteers

Healthy Volunteer

Belgium
Regeneron Pharmaceuticals

Completed

Study of a Single Subcutaneous Dose of Pozelimab Produced From Two Different Manufacturing Processes in Healthy Adult Participants

Healthy Volunteer

Belgium

3

Subscribe